Cluster headache in Greece: an observational clinical and demographic study of 302 patients

por Vikelis, Michail, Rapoport, Alan M.
Publicado 2016

Investigation of Frequency-Specific Loudness Discomfort Levels in Listeners With Migraine: A Case–Control Study

por Mourgela, Angeliki, Vikelis, Michail, Reiss, Joshua D.
Publicado 2023

Sumatriptan transdermal iontophoretic patch (NP101-Zelrix™): review of pharmacology, clinical efficacy, and safety in the acute treatment of migraine

por Vikelis, Michail, Mitsikostas, Dimos D, Rapoport, Alan M
Publicado 2012

Assessing the Significance of the Circadian Time of Administration on the Effectiveness and Tolerability of OnabotulinumtoxinA for Chronic Migraine Prophylaxis

por Dermitzakis, Emmanouil V., Vikelis, Michail, Vlachos, George S., Argyriou, Andreas A.
Publicado 2022

Prospective Comparison of Longer Needle Lengths to Assess the Risk of OnabotulinumtoxinA-Associated Neck Pain in Patients with Chronic Migraine

por Dermitzakis, Emmanouil V., Vikelis, Michail, Vlachos, George S., Argyriou, Andreas A.
Publicado 2022

OnabotulinumtoxinA Add-On to Monoclonal Anti-CGRP Antibodies in Treatment-Refractory Chronic Migraine

por Argyriou, Andreas A., Dermitzakis, Emmanouil V., Xiromerisiou, Georgia, Vikelis, Michail
Publicado 2022

Reliability and Validity of the Greek Migraine Disability Assessment (MIDAS) Questionnaire

por Oikonomidi, Theodora, Vikelis, Michail, Artemiadis, Artemios, Chrousos, George P., Darviri, Christina
Publicado 2017

A prospective non-interventional study for evaluation of quality of life in patients with Alzheimer’s disease treated with rivastigmine transdermal patch

por Vagenas, Vassileios, Vlachos, Georgios S, Vlachou, Nikoleta, Liakopoulos, Dimitrios, Kalaitzakis, Michail E, Vikelis, Michail
Publicado 2015

Onabotulinumtoxin-A treatment in Greek patients with chronic migraine

por Vikelis, Michail, Argyriou, Andreas A., Dermitzakis, Emmanouil V., Spingos, Konstantinos C., Mitsikostas, Dimos D.
Publicado 2016

Clinical experience with transcutaneous supraorbital nerve stimulation in patients with refractory migraine or with migraine and intolerance to topiramate: a prospective explorator...

por Vikelis, Michail, Dermitzakis, Emmanouil V., Spingos, Konstantinos C., Vasiliadis, Georgios G., Vlachos, George S., Kararizou, Evaggelia
Publicado 2017

Sustained onabotulinumtoxinA therapeutic benefits in patients with chronic migraine over 3 years of treatment

por Vikelis, Michail, Argyriou, Andreas A., Dermitzakis, Emmanouil V., Spingos, Konstantinos C., Makris, Nikolaos, Kararizou, Evangelia
Publicado 2018

Results of a Web-based survey of 2105 Greek migraine patients in 2020: demographics, clinical characteristics, burden and the effects of the COVID-19 pandemic on the course of migr...

por Dermitzakis, Emmanouil V., Kouroudi, Aikaterini, Argyriou, Andreas A., Spingos, Konstantinos C., Bilias, Konstantinos, Vikelis, Michail
Publicado 2022

Results of a Web-Based Survey on 2105 Greek Migraine Patients—Second Part: Efficacy of Acute and Prophylactic Migraine Treatments and Corresponding Patients’ Reported Satisfaction...

por Dermitzakis, Emmanouil V., Kouroudi, Aikaterini, Argyriou, Andreas A., Spingos, Konstantinos C., Bilias, Konstantinos, Vikelis, Michail
Publicado 2022

Predictors of Response to Fremanezumab in Migraine Patients with at Least Three Previous Preventive Failures: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek Regi...

por Argyriou, Andreas A., Dermitzakis, Emmanouil V., Xiromerisiou, Georgia, Rallis, Dimitrios, Soldatos, Panagiotis, Litsardopoulos, Pantelis, Vikelis, Michail
Publicado 2023

Single OnabotulinumtoxinA Session Add-On to Carbamazepine or Oxcarbazepine in Treatment-Refractory Trigeminal Neuralgia: A Case Series with 24-Week Follow Up

por Xiromerisiou, Georgia, Lampropoulos, Ioannis C., Dermitzakis, Emmanouil V., Vikelis, Michail, Marogianni, Chrysoula, Mysiris, Dimitrios, Argyriou, Andreas A.
Publicado 2023

Effects of Fremanezumab on Psychiatric Comorbidities in Difficult-to-Treat Patients with Chronic Migraine: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek Registr...

por Vikelis, Michail, Dermitzakis, Emmanouil V., Xiromerisiou, Georgia, Rallis, Dimitrios, Soldatos, Panagiotis, Litsardopoulos, Pantelis, Rikos, Dimitrios, Argyriou, Andreas A.
Publicado 2023

Genetic Variability in Vitamin D Receptor and Migraine Susceptibility: A Southeastern European Case-Control Study

por Papasavva, Maria, Vikelis, Michail, Siokas, Vasileios, Katsarou, Martha-Spyridoula, Dermitzakis, Emmanouil V., Raptis, Athanasios, Dardiotis, Efthimios, Drakoulis, Nikolaos
Publicado 2023

Patients’ preferences for headache acute and preventive treatment

por Mitsikostas, Dimos D., Belesioti, Ioanna, Arvaniti, Chryssa, Mitropoulou, Euthymia, Deligianni, Christina, Kasioti, Elina, Constantinidis, Theodoros, Dermitzakis, Manolis, Vikelis, Michail
Publicado 2017

Open Label Prospective Experience of Supplementation with a Fixed Combination of Magnesium, Vitamin B2, Feverfew, Andrographis Paniculata and Coenzyme Q10 for Episodic Migraine Pro...

por Vikelis, Michail, Dermitzakis, Emmanouil V., Vlachos, George S., Soldatos, Panagiotis, Spingos, Konstantinos C., Litsardopoulos, Pantelis, Kararizou, Evangelia, Argyriou, Andreas A.
Publicado 2020

Variability in oxidative stress-related genes (SOD2, CAT, GPX1, GSTP1, NOS3, NFE2L2, and UCP2) and susceptibility to migraine clinical phenotypes and features

por Papasavva, Maria, Vikelis, Michail, Siokas, Vasileios, Katsarou, Martha-Spyridoula, Dermitzakis, Emmanouil V., Raptis, Athanasios, Kalliantasi, Aikaterini, Dardiotis, Efthimios, Drakoulis, Nikolaos
Publicado 2023